Latest Breaking News On - Inebilizumab reduces attack risk independent - Page 1 : comparemela.com

Horizon Therapeutics (HZNP) to Present UPLIZNA Data in Neuromyelitis Optica Spectrum Disorder

Horizon Therapeutics (HZNP) to Present UPLIZNA Data in Neuromyelitis Optica Spectrum Disorder
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesRachel vannMandeep kaurNeuroimmunol neuroinflammNeuromyelitis opticaTina venturaEuropean commissionProduct communicationsDrug administrationAmerican academy of neurologyBrazilian health regulatory agencyExchange commissionAnnual meetingDisease activityTrial receiving inebilizumab treatmentImmunosuppression treatment

Horizon Therapeutics plc Announces UPLIZNA® (inebilizumab-cdon) Data in Neuromyelitis Optica Spectrum Disorder (NMOSD) to be Presented at the 2023 American Academy of Neurology (AAN) Annual Meeting

Oral presentation on the relationship between B-cell subsets and NMOSD attacks to be held on April 23 at 1:48 p.m. EDT . | April 20, 2023

United statesNeuroimmunol neuroinflammNeuromyelitis opticaMandeep kaurAmerican academy of neurologyDrug administrationExchange commissionEuropean commissionBrazilian health regulatory agencyHorizon therapeuticsAnnual meetingDisease activityTrial receiving inebilizumab treatmentImmunosuppression treatmentInebilizumab reduces attack risk independentLow affinity igg fc region receptor